The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
about
MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signalingThe PHR proteins: intracellular signaling hubs in neuronal development and axon degenerationThe Nesprin family member ANC-1 regulates synapse formation and axon termination by functioning in a pathway with RPM-1 and β-CateninA fly's view of neuronal remodelingRPM-1 uses both ubiquitin ligase and phosphatase-based mechanisms to regulate DLK-1 during neuronal developmentDeath Receptor 6 Promotes Wallerian Degeneration in Peripheral Axons.Developmental Function of the PHR Protein RPM-1 Is Required for Learning in Caenorhabditis elegans.Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivoA rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degenerationMetabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.SkpA restrains synaptic terminal growth during development and promotes axonal degeneration following injuryRapid in vivo forward genetic approach for identifying axon death genes in DrosophilaA role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stressNMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector.Preserve and protect: maintaining axons within functional circuits.Identification of a peptide inhibitor of the RPM-1 · FSN-1 ubiquitin ligase complexAbsence of SARM1 rescues development and survival of NMNAT2-deficient axons.Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury.Expression profile of a Caenorhabditis elegans model of adult neuronal ceroid lipofuscinosis reveals down regulation of ubiquitin E3 ligase components.Sculpting neural circuits by axon and dendrite pruningTMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance.Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules.An evolutionarily conserved mechanism for cAMP elicited axonal regeneration involves direct activation of the dual leucine zipper kinase DLKSarm1-mediated axon degeneration requires both SAM and TIR interactionsJNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis.New approaches for studying synaptic development, function, and plasticity using Drosophila as a model systemLoss of the spectraplakin short stop activates the DLK injury response pathway in Drosophila.Sodium and potassium currents influence Wallerian degeneration of injured Drosophila axons.Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.Diversification of NAD biological role: the importance of location.Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.Concepts for regulation of axon integrity by enwrapping glia.Drosophila models of neuronal injuryDiverse cellular and molecular modes of axon degeneration.Wallerian degeneration: an emerging axon death pathway linking injury and disease.Signaling mechanisms regulating Wallerian degeneration.A unified cell biological perspective on axon-myelin injury.Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.Mechanisms of distal axonal degeneration in peripheral neuropathies.
P2860
Q21089746-766C06F9-639C-4473-AF5B-233E725DA90BQ26752306-A86ECF9E-5582-44D8-BDF0-5683576D2F31Q27314937-9008811A-413A-4BE2-B147-F79664CF5049Q28068381-F856F8F5-3F79-482B-A5B7-28F0952D7719Q28538585-32303984-C53B-417B-BE7B-B87DCFF864E8Q30252985-822205DE-39F9-4ECE-9638-D4FC480F487BQ30395751-8FFBF0CA-EFE3-46B3-BBCA-F374F2EDAB91Q30543899-91C6B941-92DF-472E-8CE6-AB8FAF00A4BBQ30638030-87122069-A7D0-4380-96BD-A22492973EC4Q30656970-C37C852E-FFAB-4CD1-9D61-0BC61AED8245Q33770371-D7FAA2D2-0485-431C-806D-64E0DE7C39F3Q33919735-41CCD8CE-2096-4D54-A8D8-18CA7C4EC655Q33985200-B7828B43-1743-4D14-B91A-15E96E901388Q34555880-A4040350-35D2-44A5-AFCD-9BA733128E1AQ34575680-93844A37-485E-4722-A269-58AAB042C6FBQ34683242-8FE10810-1510-4A51-B83B-4DEBE5365BE4Q35275832-E000412D-9453-4CBD-B33A-0579D889F3F2Q35472270-66E8BAEA-2990-40A6-9B15-E717397CC73EQ36099459-CE71060A-6290-4917-BC09-E93215E6C953Q36344881-8560A43C-019A-407D-AF6D-CF64AD482FCEQ36840516-649B53BB-5A0E-45FE-A8D7-02DFA0472F40Q36932922-90CD7F25-F765-4EB3-AC37-3A73F803863EQ36978295-D0E7F2A3-6098-4041-A6C7-ED8A3B6E7C30Q37093933-BCF560B4-BBF2-4BED-9219-9724E54F1325Q37141102-1309C076-A7A3-4A3C-995B-45251432B6D1Q37282538-7E691BB8-B844-401B-B453-3A2F89AA66FCQ37282607-FB913642-C954-4351-BFB5-8F78D5A46FC7Q37345123-6A42E26D-9390-4518-B5F6-8665128D3F4DQ37534326-4048F49C-BFFA-479A-BC7F-5B29F115713EQ37590373-67BDFB9A-CDC3-4967-A742-2352543014D7Q38121170-D245FEAA-D6AC-4846-AFF6-46EF95422AB9Q38170006-A1CE3AFB-86DA-4EF2-B9BB-BF9241A60942Q38175969-95E7D4C8-FD61-4ADF-9FA3-F028F48BDCC7Q38194948-4DD344FA-9286-4ED5-BEB9-B2FEF17E5BC6Q38208077-E4F85209-B01C-42AF-B81E-9C638476D7EFQ38212791-5E845541-5DEC-48E0-8A3F-A708C3686F80Q38218414-6AB7D5D5-ABA8-4129-9DB7-1AAC1CB5C8D0Q38237032-BD6E9FFE-AF53-4EAE-B188-1D873D4D15C6Q38265736-E6E69C9D-7F27-498B-B843-D0C6F57E7746Q38330759-AF678339-4281-41A9-9D32-520155A8902F
P2860
The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
@en
type
label
The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
@en
prefLabel
The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
@en
P2093
P2860
P1433
P1476
The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction.
@en
P2093
Aaron DiAntonio
Bogdan Beirowski
Elisabetta Babetto
Emilie V Russler
Jeffrey Milbrandt
P2860
P304
P356
10.1016/J.CELREP.2013.04.013
P577
2013-05-09T00:00:00Z